Compare UFG & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFG | IRIX |
|---|---|---|
| Founded | 2021 | 1989 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 20.2M |
| IPO Year | 2025 | 1996 |
| Metric | UFG | IRIX |
|---|---|---|
| Price | $0.65 | $1.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 323.8K | 86.5K |
| Earning Date | 10-28-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $195,620,824.00 | $50,647,000.00 |
| Revenue This Year | $41.40 | $9.61 |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | $131.70 | ★ N/A |
| Revenue Growth | ★ 49.71 | 4.58 |
| 52 Week Low | $0.60 | $0.78 |
| 52 Week High | $11.00 | $1.87 |
| Indicator | UFG | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 32.86 | 58.35 |
| Support Level | $0.80 | $1.10 |
| Resistance Level | $0.83 | $1.24 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 15.45 | 63.08 |
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.